CEO Won-seok Lee Increases Stake from 8.21% to 8.27% via Open Market Purchase... Insider Buying Signals Perceived Undervaluation


  • CEO Won-seok Lee acquired 9,166 common shares through open market purchases on May 29, 2026 (average price approx. 6,228 won).
  • Stake increased from 8.21% to 8.27% (0.06%p), total holdings now 1,187,365 shares.
  • Insider buying is interpreted as a positive signal regarding company value and may indicate willingness to support stock price.
  • [AI Comprehensive Analysis]Although the purchase volume is small, insider buying by management enhances credibility. However, the minimal change in stake limits near-term impact on stock price.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Daehan Nupharm (054670)
  • Submission: Won-seok Lee
  • Receipt: 05-29-2026